HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipoprotein X in a patient with cholestasis and hypertriglyceridaemia.

Abstract
Hypertriglyceridaemia is an established cause of acute pancreatitis and responds to insulin therapy in addition to lipid lowering medication. We report a case of severe hypertriglycaeridemia of 149 mmol/L in a 36-year-old man with type 2 diabetes who presented to the surgical ward with abdominal pain due to pancreatitis and developed acute cholestasis, jaundice and eruptive xanthomata. His triglycerides improved to 3.8 mmol/L with sliding scale insulin within two weeks of in-hospital stay. However, his total cholesterol remained raised at 23.7 mmol/L. The lipoprotein electrophoresis confirmed the presence of lipoprotein X associated with bile obstruction, which contributed to an increase in total cholesterol. The total cholesterol normalized on improvement of his cholestasis.
AuthorsKarolina M Stepien, Hrushikesh Divyateja, Farhan Ahmed, Peter Prinsloo, Pankaj Gupta
JournalAnnals of clinical biochemistry (Ann Clin Biochem) Vol. 50 Issue Pt 2 Pg. 173-5 (Mar 2013) ISSN: 1758-1001 [Electronic] England
PMID23431481 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Lipoprotein-X
Topics
  • Adult
  • Cholestasis (blood, complications, therapy)
  • Diabetes Mellitus, Type 2 (complications)
  • Humans
  • Hypertriglyceridemia (complications)
  • Lipoprotein-X (blood)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: